Aquatic Capital Management LLC bought a new stake in Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 20,031 shares of the financial services provider's stock, valued at approximately $965,000.
A number of other hedge funds also recently made changes to their positions in the company. Amundi grew its position in shares of Trupanion by 193.2% during the fourth quarter. Amundi now owns 16,828 shares of the financial services provider's stock worth $784,000 after buying an additional 11,088 shares in the last quarter. Barclays PLC grew its stake in Trupanion by 259.2% during the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock worth $2,750,000 after buying an additional 47,262 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Trupanion by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock worth $173,362,000 after acquiring an additional 45,653 shares during the period. Wealthfront Advisers LLC bought a new stake in shares of Trupanion during the fourth quarter valued at approximately $845,000. Finally, Illinois Municipal Retirement Fund bought a new position in shares of Trupanion in the fourth quarter worth $834,000.
Insider Buying and Selling
In other news, CFO Fawwad Qureshi sold 1,373 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the sale, the chief financial officer now owns 2,416 shares of the company's stock, valued at $82,675.52. This trade represents a 36.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Emily Dreyer sold 14,025 shares of the company's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the transaction, the senior vice president now owns 27,645 shares in the company, valued at $895,974.45. This represents a 33.66 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,792 shares of company stock valued at $1,122,802. 5.50% of the stock is owned by corporate insiders.
Trupanion Price Performance
TRUP stock traded up $8.56 on Friday, hitting $45.00. 1,622,126 shares of the company's stock traded hands, compared to its average volume of 653,911. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. The stock has a market cap of $1.91 billion, a price-to-earnings ratio of -195.65, a P/E/G ratio of 6.02 and a beta of 1.66. Trupanion, Inc. has a 1-year low of $20.05 and a 1-year high of $57.90. The stock has a fifty day moving average of $35.60 and a 200-day moving average of $44.88.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. The business had revenue of $341.98 million during the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The company's revenue was up 11.7% compared to the same quarter last year. During the same period last year, the company posted ($0.16) EPS. On average, analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of research firms have commented on TRUP. Piper Sandler dropped their price target on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Stifel Nicolaus dropped their target price on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a report on Thursday, February 20th. Finally, Lake Street Capital decreased their price target on Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research note on Friday. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $51.80.
Read Our Latest Report on Trupanion
Trupanion Company Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.